STAPLEFORD-ATHENS 2008
BASIC PROGRAMME
Park Hotel Athens 24-26 May 2008

Friday May 23rd. 7.30pm Informal reception

Saturday May 24th.

08.00 Registration

09.00 Introduction. Y. Kasvikis. Athens.

SESSION 1. Rapid Opiate Detoxification (ROD)

09.15 Mortality in ROD under anaesthesia in experienced hands: a global review. C. Brewer. London.

09.45 Discussion

10.00….A new technique for Accelerated Opiate Detoxification. N Maksoud, Cairo.

10.30 Discussion.

10.45 Coffee break

11.15 Day-patient ROD and implantation. Experience with over 9000 cases. George O’Neil. Perth WA.

11.45 Discussion

12.00 In-patient detoxification and retention: the Detox-5 model. M Carr, Harrogate UK.

12.20 Rapid opiate detox vs 7-9 day home detox: outcomes. B Lysakowska, Warsaw.

12.40 Errors in official meta-analyses of opiate detoxification techniques by Britain’s National Institute for Clinical Excellence (NICE) A. Bakker. London

13.00 – 14.00 Lunch

SESSION 2. Randomised Controlled Trials (RCTs) of naltrexone implants in opiate dependence.

14.00….Multi-centre double-blind, double-dummy trial of Prodetoxone implant. E Krupitzky, St Petersburg.

14.25 Double-blind, double-dummy trial of the O’Neil long-acting implant. G Hulse. Perth.

14.50 Discussion

15.00 Tissue compatibility, biodegradation and pharmacokinetics of O’Neil implants. G. Hulse.

15.15 RCT of O’Neil implant vs Methadone Maintenance in discharged prisoners. P. Lobmaier, Oslo

15.40 RCT of ‘usual care’ vs usual care + O’Neil implant in detoxified heroin addicts. N. Kunoe. Oslo.

16.05 Tea break

16.20 Discussion

16.40 Development of an on-line audit and research facility for implant patients. M.Ross. Bradford. UK.

17.00 Failure of theoretically adequate naltrexone blood level to prevent opiate agonist breakthrough by heroin or methadone. a report of two cases and introducing the phenomenon of pseudo-breakthough. R.Tovey, London.

17.15 End of session.

19.30. Reception and dinner. Inauguration of ISTAA – the International Society for the Treatment of Addiction with Antagonists

 

 

Sunday May 25th.

SESSION 3. Advances in testing for drugs of abuse and treatments for alcohol, cocaine and benzodiazepine (BDZ) abuse.

09.00 12-month outcomes of an RCT of disulfiram, acamprosate and naltrexone in alcoholism. H.Alho. Helsinki

09.20 Discussion

9.30 CAMELOTT. Long-term abstinence and maintenance for a neurobiological age. J.Currie. Melbourne.

10.00 Out-patient ambulatory rapid BDZ detoxification. G.O’Neil. Perth.

10.30 Discussion.

10.40 Coffe break

11.00 Individualised BDZ detoxification optimised by clinical and serum monitoring. A. Basinska-Starzycka. Warsaw

11.25 Experience with flumazenil in rapid BDZ detoxification. P.Coleman. Richmond VA. USA

11.45 Latest trials of Vivitrol depot-naltrexone in alcoholism. D. Gastfriend. Cambridge. MA. USA

12.10 Developments in hair testing for drugs of abuse. J. Wicks. Cardiff.

12.30 Experience with long-acting Chinese implants. R. Colquhoun. Sydney.

12.45 Discussion

13.00 Lunch

14.00 SESSION 4. Maintenance with methadone, buprenorphine and other opioids.

14.00 Review and update of methadone and buprenorphine in maintenance. N. Lintzeris, Sydney

14.45 Discussion.

15.00 QTc prolongation in the Warsaw methadone maintenance program. B. Habrat. Warsaw.

15.20 Emerging intravenous drug use in Kenya: the need to develop appropriate response policies. D. Ndtei. Nairobi

15.40 Commissioning criminal justice drug services through service user consultation: South Wales drugs intervention programme. G.Davies. Cardiff. UK.

16.00 The neural mechanisms for drug addiction. R. Colquhoun. Sydney.

16.30 Discussion and closing remarks.

16.45 End of session and of presentations.

 

Monday May 25th.

08.45 – 11.00 WORKSHOPS (according to demand).

Workshop 1. Techniques and issues in depot and implanted naltrexone for opiate abuse.

Workshop 2. Techniques of antagonist-precipitated opiate detoxification.

Workshop 3. Clinical and organisational issues in opioid maintenance.

11.00 End of conference